A Phase I, Single Centre, Open-Label Study to Assess the Pharmacokinetics of Both AZD9056 (Steady State) and Simvastatin (Single Dose) When Co-Administered in Healthy Volunteers.

Trial Profile

A Phase I, Single Centre, Open-Label Study to Assess the Pharmacokinetics of Both AZD9056 (Steady State) and Simvastatin (Single Dose) When Co-Administered in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2010

At a glance

  • Drugs AZD 9056 (Primary) ; Simvastatin
  • Indications Hyperlipidaemia; Osteoarthritis; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Dec 2010 Additional trial location (Germany) identified as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Actual end date changed from Nov 2008 to Sep 2008 as reported by ClinicalTrials.gov.
    • 08 Jan 2009 Actual end date changed from Sep 2008 to Nov 2008 as reported by Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top